Jonathan C. Shaver, MD Orthopaedic Surgery - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 576 Fort Loudoun Medical Center Dr Ste 100, Lenoir City, TN 37772 Phone: 865-988-8667 Fax: 865-988-8837 |
Dr. Andrew James Maclellan, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 460 Medical Park Dr, Suite 104, Lenoir City, TN 37772 Phone: 865-986-7737 Fax: 865-986-7807 |
News Archive
When the arteries delivering oxygen to our vital organs are obstructed by atherosclerosis or clots, the result is almost always a stroke, heart attack or damage to a peripheral tissue such as the legs (peripheral artery disease). But the severity of tissue injury or destruction from a choked-off blood supply varies from person to person, and may depend in large part on whose circulatory system has the best back-up plan to provide alternate routes of circulation.
Abnormalities in the fibers connecting different brain areas may contribute to muscle disorders such as writer's cramp, according to a report in the April issue of Archives of Neurology.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the Phase I clinical study assessing Inovio's PENNVAX-B DNA vaccine delivered using its proprietary electroporation technology in a preventive setting has fully completed the enrollment of 48 healthy volunteers. The multi-center study is being conducted by Inovio's clinical collaborator, the HIV Vaccine Trials Network (HVTN), at several clinical sites under a protocol designated HVTN-080.
Researchers of the Universitat Politècnica de València and the Hospital Universitari i Politècnic La Fe have developed a new application, currently in beta phase, to facilitate the movement of people around the city of Valencia (Spain), specially those who have temporary or permanent reduced mobility. Furthermore, it will warn users of any urban barrier in a simple and intuitive way.
Genta Incorporated today announced that tesetaxel, the leading oral taxane in clinical development, has been designated as an Orphan Drug by the European Medicines Agency for gastric cancer. The drug has previously received Orphan Drug designation by the U.S. Food and Drug Administration for both gastric cancer and melanoma, as well as Fast Track designation by FDA for gastric cancer.
› Verified 3 days ago